- £14.55m
- £12.51m
- £19.58m
- 73
- 46
- 40
- 52
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.1 | 4.36 | 7.7 | 13.7 | 19.6 |
Cost of Revenue | |||||
Gross Profit | 0.885 | 1.45 | 2.37 | 3.26 | 5.24 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.29 | 4.15 | 7.59 | 14.2 | 19.3 |
Operating Profit | -0.183 | 0.211 | 0.114 | -0.511 | 0.251 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.183 | 0.188 | 0.13 | -0.567 | 0.048 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.183 | 0.188 | 0.389 | -0.701 | 0.05 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.183 | 0.188 | 0.389 | -0.701 | 0.05 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.183 | 0.188 | 0.389 | -0.701 | 0.05 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.023 | 0.019 | 0.058 | -0.024 | 0.006 |
Dividends per Share |